In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.
Signed informed consent
Diagnosis of inflammatory bowel disease according to actual guidelines (Porto Criteria)
General good health
Ability to understand and follow study procedures and understand informed consent
Participation in other clinical studies interfering with study procedures.
Inability or contraindications to undergo the investigated intervention
Severe or acute flare of disease (for UC PUCAI score ≥35, for CD wPCDAI >40)
Treatment escalation within last 4 weeks for uncontrolled disease.
Insel Gruppe AG, University Hospital Bern
Lead sponsor
Clinical Trials Unit University of Bern
Collaborator
University of Bern
Collaborator